Barricaid
Latest round
- Series H
Last raised
- Mar 2017
Total raised
- $138M
Investors
- 9
About Barricaid
Intrinsic Therapeutics, Inc.Intrinsic Therapeutics, Inc. specializes in medical devices for lumbar herniated disc treatment.91 mn.93 mn.Intrinsic Therapeutics specializes in innovative solutions for lumbar herniated disc treatment, with its flagship product being the Barricaid bone-anchored implant. This device is the first of its kind to have clinical validation demonstrating its efficacy in reducing reherniation and the need for reoperation among patients with significant annular defects. Designed for individuals at high risk of complications post-discectomy, Barricaid optimizes surgical outcomes and alleviates associated debilitating pain. The company targets a diverse client base, including patients undergoing spinal surgery and the surgeons who perform these procedures, primarily within the United States.S.Intrinsic Therapeutics generates revenue primarily through the sale of its Barricaid implant to healthcare facilities and surgical centers specializing in spinal procedures. The transaction model typically involves direct sales to hospitals and outpatient surgery centers, where the implant is utilized during discectomy surgeries. Pricing structures for the Barricaid device are determined by agreements with healthcare providers, ensuring competitive rates for hospitals while maintaining profitability for the company. Given the focus on clinical evidence and patient outcomes, the sales process is supported by educational initiatives for surgeons, enhancing product adoption and facilitating recurring purchases as new patients undergo treatment.Intrinsic Therapeutics aims to expand its market presence by introducing new products designed for lumbar disc treatment. Plans are also in place to explore opportunities for expansion in new geographic regions, focusing on increasing market share within the United States, with a potential eye towards future international markets, although specific timelines for these expansions have yet to be disclosed. Additionally, the firm recently saw New Leaf Venture Partners realize its investment, indicating strategic shifts towards growth and sustainability.
Who invested in Barricaid
9 investors across 9 rounds
See all investors in Barricaid
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series H
Mar 21, 2017
Amount
$11M
Investors
Series H
Dec 1, 2016
Amount
$18M
Investors
Series G
Aug 22, 2014
Amount
$17M
Investors
Series F
Oct 26, 2012
Amount
$12M
Investors
Series E
Jun 17, 2010
Amount
$9.8M
Investors
Series E
Feb 12, 2010
Amount
$18M
Investors
Series D
Jul 10, 2007
Amount
$21M
Investors
Series C
Dec 27, 2002
Amount
$25M
Investors
Series B
Jan 3, 2001
Amount
$7.5M
Investors
Questions about Barricaid
Who invested in Barricaid?
Barricaid has 9 investors on record across 9 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Barricaid raised?
Barricaid has raised 9 venture rounds. Sign up free to see how much each round raised and the total.
When did Barricaid last raise money?
Barricaid's most recent round on record is a Series H, in Mar 2017.
What does Barricaid do?
Barricaid is a medical devices & equipment company.
Where is Barricaid headquartered?
Barricaid is headquartered in Woburn, US.
Which VCs invest in companies like Barricaid?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Barricaid's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series H
Raising like Barricaid? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.